Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DeepScribe
AddedFeb 15, 2024
UpdatedJun 18, 2026
DeepScribe

DeepScribe

Series A

AI-powered platform, DeepScribe, enhances physician efficiency and patient outcomes in healthcare.

HQ
San Francisco, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
News
Website

Founded with the mission to enhance physician efficiency and patient outcomes, DeepScribe leverages AI technology to transform the healthcare industry. The company offers an AI-powered medical scribe platform that captures clinical conversations with high accuracy using advanced speech recognition technology. Their services include customizable AI-generated notes tailored to provider workflows, aiming to improve clarity, trust, and understanding between physicians and patients.

Notable figures associated with DeepScribe include Dr. Dean Dalili, who serves as the Chief Medical Officer, driving clinical excellence and innovation. The company has achieved significant milestones in improving healthcare documentation efficiency and has garnered attention for its impact on reducing physician burnout and enhancing patient care. Through its innovative solutions, DeepScribe has made a substantial impact on the healthcare sector by streamlining administrative tasks and allowing physicians to focus more on patient care.

DeepScribe - Similar Companies

Abridge logo

Abridge

DeepScribe - Quick Facts

Who are DeepScribe's competitors?

Companies similar to DeepScribe include Abridge.

When was DeepScribe founded?

DeepScribe was founded in 2017.

Where is DeepScribe's headquarters located?

DeepScribe's headquarters is located in San Francisco, CA, US.

When was DeepScribe's last funding round?

DeepScribe's most recent funding round was for $30M (USD) in January 2022.

How much has DeepScribe raised to-date?

As of Jan 11, 2022, DeepScribe has raised a total of $37.2M (USD).

How many employees does DeepScribe have?

DeepScribe has 137 employees as of Feb 5, 2024.

DeepScribe - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
  • Speech Recognition
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • AI Documentation
  • AI Medical Documentation
  • Medical Scribe
  • Medical Scribe Software
Tags
  • AI
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified